| Period Ending | Dec 30, 2012 | Dec 30, 2011 | Dec 30, 2010 |
|---|
|
Total Revenue
|
15,215,000
|
12,988,000
|
10,221,000
| | Cost of Revenue | 11,855,000 | 9,678,000 | 7,590,000 | | |
Gross Profit
|
3,360,000
|
3,310,000
|
2,631,000
| |
|
Operating Expenses |
|
Research Development | 257,000 | 245,000 | 216,000 |
|
Selling General and Administrative | 2,040,000 | 1,758,000 | 1,641,000 |
|
Non Recurring | 793,000 |
-
|
-
|
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
298,000
|
1,307,000
|
774,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (72,000) | (107,000) | (171,000) |
|
Earnings Before Interest And Taxes | 198,000 | 1,200,000 | 603,000 |
|
Interest Expense | 486,000 | 453,000 | 406,000 |
|
Income Before Tax | (288,000) | 747,000 | 197,000 |
|
Income Tax Expense | 462,000 | 542,000 | 396,000 |
|
Minority Interest | (28,000) | (16,000) | (18,000) |
|
|
|
Net Income From Continuing Ops | (778,000) | 189,000 | (217,000) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
(778,000)
|
189,000
|
(217,000)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(778,000)
|
189,000
|
(217,000)
|
|